Buscar resultados de ensayos clínicos

Patrocinado por

Pulmonary Eosinophilia - 20 Studies Found

Estado Estudiar
Completed Nombre del estudio: A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
Condición: Eosinophilic Asthma
Fecha: 2011-01-25
Intervenciones:
  • Drug: Reslizumab Patients were
Completed Nombre del estudio: A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Condición: Eosinophilic Asthma
Fecha: 2010-12-29
Intervenciones:
  • Drug: Reslizumab 3.0 mg/kg or

Terminated Nombre del estudio: Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma
Condición: Eosinophilic Asthma
Fecha: 2011-02-04
Intervenciones: Drug: Reslizumab Reslizumab (3.0 mg/kg) administered intravenously by infusion every 28 days (±7 da
Completed Nombre del estudio: A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Condición: Eosinophilic Asthma
Fecha: 2011-01-28
Intervenciones:
  • Drug: Reslizumab Patients were
Completed Nombre del estudio: A Phase IIa Study of KHK4563
Condición: Uncontrolled and Suspected Eosinophilic Asthma
Fecha: 2011-08-07
Intervenciones:
  • Drug: KHK4563 every 4 weeks fo
Completed Nombre del estudio: Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma
Condición: Severe Eosinophilic Asthma
Fecha: 2015-09-04
Intervenciones:
  • Drug: OC000459
  • Drug: Placebo
Completed Nombre del estudio: Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Condición: Eosinophilic Asthma
Fecha: 2012-01-03
Intervenciones:
  • Drug: Reslizumab Reslizumab ad
Active, not recruiting Nombre del estudio: Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study
Condición: Asthma
Fecha: 2015-08-31
Intervenciones:
  • Drug: Mepolizumab 100 mg SC ev
Completed Nombre del estudio: Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients
Condición: Asthma
Fecha: 2015-09-17
Intervenciones:
  • Biological: Mepolizumab 100mg

Completed Nombre del estudio: Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
Condición: Asthma
Fecha: 2014-10-30
Intervenciones:
  • Biological: Mepolizumab Humani
Next >>>